Form 4: ABEONA CEO Sells Shares for Tax Obligations

ABEONA THERAPEUTICS CEO Vishwas Seshadri sold 249 shares of common stock on October 16, 2025, to cover tax obligations related to restricted stock vesting.

Summary

• Vishwas Seshadri, Chief Executive Officer and Director of ABEONA THERAPEUTICS INC. (ABEO), reported a transaction on October 16, 2025.
• Seshadri disposed of 249 shares of common stock at a price of $5.485 per share.
• The sale was executed to cover tax obligations associated with the vesting of restricted stock awards.
• Following this transaction, Seshadri beneficially owns 1,189,818 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is neutral as it is a non-discretionary sale to cover tax obligations from restricted stock vesting, rather than a discretionary sale based on market outlook.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• The sale reported was to cover tax obligations associated with the vesting of restricted stock awards.

Industry Context

This filing reports an individual insider transaction, which is a routine disclosure for executives and directors. It does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of a small number of shares for tax purposes by a key executive is generally not considered a significant event that would materially impact shareholder value or confidence.

Key Dates

Keywords

ABEONA THERAPEUTICS, ABEO, Vishwas Seshadri, Insider Trading, Form 4, Stock Sale, Tax Obligations, Restricted Stock